Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor

Journal of Clinical and Experimental Neuropsychology

Volumn 32, Issue 4, 2010, Pages 337-349

  Hanson, Karen L ^a,b   Luciana, Monica ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

3,4 Methylenedioxymethamphetamine; Cognition; Drug use; Ecstasy; Executive function; Marijuana; Memory; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; PSYCHEDELIC AGENT;

ADDICTION; ADOLESCENT; ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; DEPTH PERCEPTION; DRUG EFFECT; FEMALE; HUMAN; INHIBITION (PSYCHOLOGY); LEARNING; MALE; NEUROPSYCHOLOGICAL TEST; NONPARAMETRIC TEST; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; RECALL; STATISTICAL MODEL;

ADOLESCENT; ADULT; COGNITION DISORDERS; FEMALE; HALLUCINOGENS; HUMANS; INHIBITION (PSYCHOLOGY); LOGISTIC MODELS; MALE; MENTAL RECALL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; SPACE PERCEPTION; STATISTICS, NONPARAMETRIC; SUBSTANCE-RELATED DISORDERS; VERBAL LEARNING; YOUNG ADULT;

EID: 77951227430     PISSN: 13803395     EISSN: 1744411X     Source Type: Journal    
DOI: 10.1080/13803390903042361     Document Type: Article

References (104)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual for mental disorders (4th ed., text rev.). Washington, DC: Author.
2. Back-Madruga, C., Boone, K. B., Chang, L., Grob, C. S., Lee, A., Nations, H., et al. (2003). Neuropsychological effects of 3,4- methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users. Clinical Neuropsychologist, 17, 446-459.
3. Beck, A. T., Ward, C. H., Mendelsohn, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561-571.
4. Bhattachary, S., & Powell, J. H. (2001). Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or "ecstasy": Evidence for cognitive impairment. Psychological Medicine, 31, 647-658.
5. Bolla, K. I., Brown, K., Eldreth, D., Tate, K., & Cadet, J. L. (2002). Dose-related neurocognitive effects of marijuana use. Neurology, 59, 1337-1343.
6. Bolla, K. I., McCann, U. D., & Ricaurte, G. A. (1998). Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology, 51, 1532-1537.
7. Braver, T. S., Barch, D. M., Gray, J. R., Molfese, D. L., & Snyder, A. (2001). Anterior cingulate cortex and response conflict: Effects of frequency, inhibition and errors. Cerebral Cortex, 11, 825-836. (Pubitemid 32800550)
8. Brown, S. A., Tapert, S. F., Granholm, E., & Delis, D. C. (2000). Neurocognitive functioning of adolescents: Effects of protracted alcohol use. Alcoholism: Clinical and Experimental Research, 24, 164-171.
9. Croft, R. J., Mackay, A. J., Mills, A. T. D., & Gruzelier, J. G. H. (2001). The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology, 153, 373-379.
10. Curran, H. V. (2000). Is MDMA (ecstasy) neurotoxic in humans? An overview of evidence and methodological problems in research. Neuropsychobiology, 42, 34-41.
11. Curran, H. V., & Travill, R. A. (1997). Mood and cognitive effects of ± 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): Week-end "high" followed by a mid-week low. Addiction, 92(7), 821-831.
12. Curran, H. V., & Verheyden, S. L. (2003). Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function. Psychopharmacology, 169, 91-103.
13. Dafters, R. I., Duffy, F., O'Donnell, P. J., & Bouquet, C. (1999). Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence. Psychopharmacology, 145, 82-90.
14. Dafters, R. I., Hoshi, R., & Talbot, A. C. (2004). Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users. Psychopharmacology, 173, 405-410.
15. Daumann, J., Fischerman, T., Heekeren, K., Thron, A., & Gouzoulis-Mayfrank, E. (2004). Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: Evidence from an 18-month longitudinal functional magnetic resonance imaging study. Biological Psychiatry, 56, 349-355.
16. Davidson, D., & Parrott, A. C. (1997). Ecstasy (MDMA) in recreational users: Self-reported psychological and physiological effects. Human Psychopharmacology: Clinical and Experimental, 12, 221-226.
17. Delis, D. C., Jacobson, M., Bondi, M. W., Hamilton, J. M., & Salmon, D. P. (2003). The myth of testing construct validity using factor analysis or correlations with normal or mixed clinical populations: Lessons from memory assessment. Journal of the International Neuropsychological Society, 9, 936-946.
18. Diwadkar, V. A., Carpenter, P. A., & Just, M. A. (2000). Collaborative activity between parietal and dorso-lateral prefrontal cortex in dynamic spatial working memory revealed by fMRI. NeuroImage, 12, 85-99.
19. Ellis, R. J., & Oscar-Berman, M. (1989). Alcoholism, aging, and functional cerebral asymmetries. Psychological Bulletin, 106, 128-147.
20. Feldman, R. S., Meyer, J. S., & Quenzer, L. F. (1997). Principles of neuropsychopharmacology. Sunderland, MA: Sinauer Associates.
21. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1997). Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P)( Version 2.0, 4/97 revision). New York: New York State Psychiatric Institute, Biometrics Research Department.
22. Fletcher, J. M., Page, J. B., Francis, D. J., Copeland, K., Naus, M. J., Davis, C. M., et al. (1996). Cognitive correlates of long-term cannabis use in Costa Rican men. Archives of General Psychiatry, 53, 1051-1057.
23. Fox, H. C., McLean, A., Turner, J. J. D., Parrott, A. C., Rogers, R., & Sahakian, B. J. (2002). Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy" ) polydrug users. Psychopharmacology, 162(2), 203-214.
24. Fox, H. C., Parrott, A. C., & Turner, J. J. D. (2001a). Ecstasy use: Cognitive deficits related to dosage rather than selfreported problematic use of the drug. Journal of Psychopharmacology, 15(4), 273-281.
25. Fox, H. C., Toplis, A. S., Turner, J. J. D., & Parrott, A. C. (2001b). Auditory verbal learning in drug-free Ecstasy polydrug users. Human Psychopharmacology: Clinical and Experimental, 16, 613-618.
26. Fray, P. J., Robbins, T. W., & Sahakian, B. J. (1996). Neuropsychiatric applications of CANTAB. International Journal of Geriatric Psychiatry, 11, 329-336.
27. Gerra, G., Zaimovic, A., Ferri, M., Zambelli, U., Timpano, M., Neri, E., et al. (2000). Long-lasting effects of (±) 3,4- methylenedioxymethamphetamine (Ecstasy) on serotonin system function in humans. Biological Psychiatry, 47, 127-136.
28. Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., et al. (1999). Brain development during childhood and adolescence: A longitudinal MRI study. Nature Neuroscience, 2, 861-863.
29. Gogtay, N., Giedd, J. N., Lusk, L., Hayashi, K. M., Greenstein, D., Vaituzis, A. C., et al. (2004). Dynamic mapping of human cortical development during childhood through early adulthood. Proceedings of the National Academy of Sciences, 101, 8174-8179.
30. Gouzoulis-Mayfrank, E., Daumann, J., Tuchtenhagen, F., Pelz, S., Becker, S., Kunert, H., et al. (2000). Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). Journal of Neurology, Neurosurgery, & Psychiatry, 68(6), 719-725.
31. Gouzoulis-Mayfrank, E., Fischermann, T., Rezk, M., Thimm, B., Hensen, G., & Daumann, J. (2005). Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use. Drug and Alcohol Dependence, 78, 317-323.
32. Gouzoulis-Mayfrank, E., Thimm, B., Rezk, M., Hensen, G., & Daumann, J. (2003). Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Progress in Neuro-Psychopharmacology, & Biological Psychiatry, 27, 819-827.
33. Grant, I., Gonzalez, R., Carey, C. L., Natarajan, L., & Wolfson, T. (2003). Nonacute (residual) neurocognitive effects of cannabis use: A meta analytic study. Journal of the International Neuropsychological Society, 9, 679-689.
34. Halpern, J. H., Pope, H. G., Jr., Sherwood, A. R., Barry, S., Hudson, J. I., & Yurgelun-Todd, D. (2004). Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs. Drug and Alcohol Dependence. 75, 135-147.
35. Hanson, K. L., & Luciana, M. (2004). Neurocognitive function in users of MDMA: The importance of clinically significant patterns of use. Psychological Medicine, 34, 229-246.
36. Hanson, K. L., Luciana, M., & Sullwold, K. (2008). Rewardrelated decision-making deficits and elevated impulsivity among MDMA and other drug users. Drug and Alcohol Dependence, 96, 99-110.
37. Heffernan, T. M., Jarvis, H., Rodgers, J., Scholey, A. B., & Ling, J. (2001). Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy. Human Psychopharmacology: Clinical and Experimental, 16, 607-612.
38. Huether, G., Zhou, D., & Rüther, E. (1997). Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners. Journal of Neural Transmission, 104, 771-794.
39. Jansma, J. M., Ramsey, N. F., Coppola, R., & Kahn, R. S. (2000). Specific versus nonspecific brain activity in a parametric N-back task. NeuroImage, 12, 688-697.
40. Kanayama, G., Rogowska, J., Pope, H. G., Gruber, S. A., & Yurgelun-Todd, D. A. (2004). Spatial working memory in heavy cannabis users: A functional magnetic resonance imaging study. Psychopharmacology, 16, 16.
41. Kendall, P. C., Hollon, S. D., Beck, A. T., Hammen, C. L., & Ingram, R. E. (1987). Issues and recommendations regarding use of the Beck Depression Inventory. Cognitive Therapy and Research, 11, 289-299.
42. Krystal, J. H., Price, L. H., Opsahl, C., Ricaurte, G. A., & Heninger, G. R. (1992). Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: Effects on mood and neuropsychological function? American Journal of Drug and Alcohol Abuse, 18(3), 331-341.
43. Kwon, L. M., Rourke, S. B., & Grant, I. (1997). Intermanual differences on motor and psychomotor tests in alcoholics: No evidence for selective right-hemisphere dysfunction. Perceptual and Motor Skills, 84, 403-414.
44. Lafayette Instrument. (1989). Instruction manual for the 32025 Grooved Pegboard Test. Lafayette, IN: Author.
45. Leung, H. C., Seelig, D., & Gore, J. C. (2004). The effect of memory load on cortical activity in the spatial working memory circuit. Cognitive, Affective & Behavioral Neurosciences, 4, 553-563.
46. Lew, R., Sabol, K. E., Chou, C., Vosmer, G. L., Richards, J., & Seiden, L. S. (1996). Methylenedioxymeth-amphetamineinduced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies. The Journal of Pharmacology and Experimental Therapeutics, 276, 855-865.
47. Lezak, M. D., Howieson, D. B., & Loring, D. W. (2004). Neuropsychological assessment (4th ed.). New York: Oxford University Press.
48. Liechti, M. E., Gamma, A., & Vollenweider, F. X. (2001). Gender differences in the subjective effects of MDMA. Psychopharmacology, 154, 161-168.
49. Luciana, M., & Collins, P. F. (1997). Dopamine modulates working memory for spatial but not object cues in normal humans. Journal of Cognitive Neuroscience, 9, 330-347.
50. Luciana, M., Collins, P. F., & Depue, R. A. (1998). Opposing roles for dopamine and serotonin in the modulation of human spatial working memory functions. Cerebral Cortex, 8, 218-226.
51. Luciana, M., Depue, R. A., Arbisi, P., & Leon, A. (1992). Facilitation of working memory in humans by a D2 dopamine receptor agonist. Journal of Cognitive Neuroscience, 4, 58-68.
52. McCann, U. D., Mertl, M., Eligulashvili, V., & Ricaurte, G. A. (1999). Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: A controlled study. Psychopharmacology, 143, 417-425.
53. McCardle, K., Luebbers, S., Carter, J. D., Croft, R. J., & Stough, C. (2004). Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology, 173, s434-s439.
54. Medina, K. L., Shear, P. K., & Corcoran, K. (2005). Ecstasy (MDMA) exposure and neuropsychological functioning: A poly drug perspective. Journal of the International Neuropsychological Society, 11, 753-765.
55. Moeller, F. G., Steinberg, J. L., Lane, S. D., Buzby, M., Swann, A. C., Hasan, K. M., et al. (2007). Diffusion tensor imaging in MDMA users and controls: Association with decision making. American Journal of Drug and Alcohol Abuse, 33, 777-789.
56. Montgomery, C., Fisk, J. E., Newcombe, R., & Murphy, P. N. (2005). The differential effects of ecstasy/polydrug use on executive components: Shifting, inhibition, updating and access to semantic memory. Psychopharmacology, 182, 262-276.
57. Morgan, M. J. (1998). Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology, 19(4), 252-264.
58. Morgan, M. J. (1999). Memory deficits associated with recreational use of "ecstasy" (MDMA). Psychopharmacology, 141, 30-36.
59. Morgan, M. J. (2000). Ecstasy (MDMA): A review of its possible persistent psychological effects. Psychopharmacology, 152, 230-248.
60. Morgan, M. J., Impallomeni, L. C., Pirona, A., & Rogers, R. D. (2006). Elevated impulsivity and impaired decision-making in abstinent ecstasy (MDMA) users compared to poly drug and drug-naïve controls. Neuropsychopharmacology, 31, 1562-1573.
61. Morgan, M. J., McFie, L., Fleetwood, L. H., & Robinson, J. A. (2002). Ecstasy (MDMA): Are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology, 159, 294-303.
62. Padula, C. B., Schweinsburg, A. D., & Tapert, S. F. (2007). Spatial working memory performance and fMRI activation interactions in abstinent adolescent marijuana users. Psychology of Addictive Behaviors, 21, 478-487.
63. Parrott, A. C. (2006). MDMA in humans: Factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. Journal of Psychopharmacology, 20, 147-163.
64. Parrott, A. C., Lees, A., Garnham, N. J., Jones, M., & Wesnes, K. (1998). Cognitive performance in recreational users of MDMA or "ecstasy": Evidence for memory deficits. Journal of Psychopharmacology, 12(1), 79-83.
65. Parrott, A. C., Milani, R. M., Parmar, R., & Turner, J. J. D. (2001). Recreational ecstasy/MDMA and other drug users from the UK and Italy: Psychiatric symptoms and psychobiological problems. Outcomes Management, 159, 77-82.
66. Parsons, O. A. (1987). Neuropsychological consequences of alcohol abuse: Many questions-some answers. In O. A. Parsons, N. Butters, & P. E. Nathan (Eds.), Neuropsychology of alcoholism (pp. 153-175). New York: Guilford Press.
67. Pope, H. G., Jr., Gruber, A. J., Hudson, J. I., Huestis, M. A., & Yurgelun-Todd, D. (2001). Neuropsychological performance in long term cannabis users. Archives of General Psychiatry, 58, 909-915.
68. Pope, H. G., Jr., & Yurgelun-Todd, D. (1996). The residual cognitive effects of heavy marijuana use in college students. JAMA, 275, 521-527.
69. Quednow, B. B., Kühn, K., Hoppe, C., Westheide, J., Maier, W., Daum, I., et al. (2007). Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("ecstasy"). Psychopharmacology, 189, 517-530.
70. Quickfall, J., & Crockford, D. (2006). Brain neuroimaging in cannabis use: A review. Journal of Neuropsychiatry and Clinical Neurosciences, 18, 318-332.
71. Reitan, R. M., & Wolfson, D. (1993). The Halsted-Reitan neuropsychological test battery: Theory and clinical interpretation (2nd ed.). Tucson, AZ: Neuropsychology Press.
72. Reneman, L., Booij, J., Schmand, B., van den Brink, W., & Gunning, B. (2000). Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology, 148, 322-324.
73. Reneman, L., Endert, E., de Bruin, K., Lavalaye, J., Feenstra, M. G., de Wolff, F. A., et al. (2002). The acute and chronic effects of MDMA ("Ecstasy") on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology, 26, 387-396.
74. Reneman, L., Lavalaye, J., Schmand, B., de Wolf, F. A., van den Brink, W., den Heeten, G. J., et al. (2001). Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylendioxymethamphetamine (MDMA or "ecstasy"): Preliminary findings. Archives of General Psychiatry, 58, 901-906.
75. Rey, A. (1964). L'examen clinique en psychologie [Clinical assessment in psychology]. Paris: Presses Universitaires de France.
76. Rogers, R., & Robbins, T. W. (2001). Investigating the neurocognitive deficits associated with chronic drug misuse. Current Opinion in Neurobiology, 11, 250-257.
77. Roiser, J. P., Rogers, R. D., Cook, L. J., & Sahakian, B. J. (2006). The effect of polymorphism at the serotonin transporter gene on decision-making, memory, and executive function in ecstasy users and controls. Psychopharmacology, 188, 213-227.
78. Sattler, J. M. (2001). Assessment of children: Cognitive applications (4th ed.). La Mesa, CA: Jerome M. Sattler.
79. Schifano, F., Di Furia, L., Forza, G., Minicuci, N., & Bricolo, R. (1998). MDMA ("ecstasy") consumption in the context of polydrug abuse: A report on 150 patients. Drug and Alcohol Dependence, 52, 85-90.
80. Schmidt, C. J. (1987). Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. The Journal of Pharmacology and Experimental Therapeutics, 240(1), 1-7.
81. Schweinsburg, A. D., Schweinsburg, B. C., Cheung, E. H., Brown, G. G., Brown, S. A., & Tapert, S. F. (2005). fMRI response to spatial working memory in adolescents with comorbid marijuana and alcohol use disorders. Drug and Alcohol Dependence, 79, 201-210.
82. Simon, N. G., & Mattick, R. P. (2002). The impact of regular ecstasy use on memory function. Addiction, 97(12), 1523-1529.
83. Solowij, N., Stephens, R. S., Roffman, R. A., Babor, T., Kadden, R., Miller, M., et al. (2002). Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA, 287, 1123-1131.
84. Sullivan, E. V., & Pfefferbaum, A. (2005). Neurocircuitry in alcoholism: A substrate of disruption and repair. Psychopharmacology, 180, 583-594.
85. Sullivan, E. V., Rosenbloom, M. J., & Pfefferbaum, A. (2000). Pattern of motor and cognitive deficits in alcoholic men. Alcoholism: Clinical and Experimental Research, 24, 611-621.
86. Tapert, S. F., & Brown, S. A. (1999). Neuropsychological correlates of adolescent substance abuse: Four-year outcomes. Journal of the International Neuropsychological Society, 5, 481-493.
87. Tapert, S. F., Brown, G. G., Kindermann, S. S., Cheung, E. H., Frank, L. R., & Brown, S. A. (2001). fMRI measurement of brain dysfunction in alcohol-dependent young women. Alcoholism: Clinical and Experimental Research, 25, 236-245.
88. Tapert, S. F., Granholm, E., Leedy, N. G., & Brown, S. A. (2002). Substance use and withdrawal: Neuropsychological functioning over 8 years in youth. Journal of the International Neuropsychological Society, 8, 873-883.
89. Tapert, S. F., Schweinsburg, A. D., Barlett, V. C., Brown, S. A., Frank, L. R., Brown, G. G., et al. (2004). Blood oxygen level dependent response and spatial working memory in adolescents with alcohol use disorders. Alcoholism, Clinical and Experimental Research, 28, 1577-1578.
90. Taylor, E. M. (1959). Psychological appraisal of children with cerebral deficits. Cambridge, MA: Harvard University Press.
91. Thomasius, R., Peterson, K., Buchert, R., Andresen, B., Zapletalova, P., Wartberg, L., et al. (2003). Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology, 167, 85-96.
92. Verbaten, M. N. (2003). Specific memory deficits in ecstasy users? The results of a meta-analysis. Human Psychopharmacology: Clinical and Experimental, 18, 281-290.
93. Verdejo-Garcia, A., Lopez-Torrecillas, F., Gimenez, C. O., & Perez-Garcia, M. (2004). Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse. Neuropsychology Review, 14, 1-41.
94. Verkes, R. J., Gijsman, H. J., Pieters, M. S. M., Schoemaker, R. C., de Visser, S., Kuijpers, M., et al. (2001). Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology, 153, 196-202.
95. Vollenweider, F. X., Gamma, A., Liechti, M., & Huber, T. (1998). Psychological and cardiovascular effects and short-term sequelae of MDMA ("Ecstasy") in MDMA-naïve healthy volunteers. Neuropsychopharmacology, 19 (4), 241-251.
96. Wareing, M., Fisk, J. E., Murphy, P., & Montgomery, C. (2005). Visuo-spatial working memory deficits in current and former users of MDMA ("ecstasy"). Human Psychopharmacology: Clinical and Experimental, 20, 115-123.
97. Wareing, M., Murphy, P. N., & Fisk, J. E. (2004). Visuospatial memory impairments in users of MDMA ("ecstasy"). Psychopharmacology, 173, 391-397. (Pubitemid 38703813)
98. Wechsler, D. (1987). Wechsler Memory Scale-Revised manual. San Antonio, TX: The Psychological Corporation.
99. Wechsler, D. (1997). Wechsler Adult Intelligence Scale-Third Edition. San Antonio, TX: The Psychological Corporation, Harcourt Brace & Company.
100. Wegner, A.-J., Gunthner, A., & Fahle, M. (2001). Visual performance and recovery in recently detoxified alcoholics. Alcohol & Alcoholism, 36, 171-179.
101. Wickens, T. D. (2002). Elementary signal detection theory. New York: Oxford University Press.
102. Yurgelun-Todd, D. A., Gruber, S. A., & Pope, H. G., Jr. (1996). Neuropsychological deficits in marijuana smokers. Biological Psychiatry, 39, 616.
103. Zakzanis, K. K., & Young, D. A. (2001). Memory impairment in abstinent MDMA ("Ecstasy") users: A longitudinal investigation. Neurology, 56, 966-969.
104. Zhang, X.-L., Begleiter, H., & Porjesz, B. (1997). Is working memory intact in alcoholics? An ERP study. Psychiatry Research: Neuroimaging Section, 75, 75-89. (Pubitemid 27435974)